Catalyst Wire Dossier Catalyst Wire Dossier

carfilzomib, cyclophosphamide, dexamethasone

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for carfilzomib, cyclophosphamide, dexamethasone, covering 2020-10-20 to 2020-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma [Phase 2]

See pricing